InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: Freeparking100 post# 4784

Saturday, 08/29/2020 12:02:01 PM

Saturday, August 29, 2020 12:02:01 PM

Post# of 13605

Cost is indicative of quality. How do you think mrna is better at negotiating than the biggest pharma companies in the world? Because they have leverage. Cost tells you a lot about who is gonna win this race. And it’s not gonna be PFE cash grabbing a vaccine that’s impossible to store and deliver effectively. Doesn’t matter if they get an EUA first.



Negotiating? You think MRNA is better at negotiating than PFE? Last I looked PFE had 1.9 billion doses pre sold, had higher T-cell counts, vax seemed to work up until age 85 and didn't have all the crazy reactions on the second dose.

They also didn't take billions from the government. MRNA has not produced anything in all the years it has been in business. So , when you have billions of Government money the negotiation part is not due to astute management, it is with the crutch of the Government.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News